Bora Lim, MD, is a medical oncologist specializing in breast oncology. She is an Associate Professor in the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, where she serves as Chief of the Section of Translational Breast Cancer Research and Director of Translational Research for the Morgan Welch Inflammatory Breast Cancer Research Program and Clinic. Clinically, Dr. Lim focuses on breast medical oncology, precision oncology, and early-phase biomarker-driven clinical trials. Her research centers on biomarker-integrated, investigator-initiated trials, liquid biopsy and circulating tumor DNA monitoring, and single-cell and proteogenomic approaches to optimize targeted therapy selection. A recognized leader, she has served as principal investigator for multiple trials, led national consortium efforts, and her work has been supported by major funding bodies including the National Cancer Institute. Prior to MD Anderson, she held leadership roles at Baylor College of Medicine’s Dan L. Duncan Comprehensive Cancer Center, including Associate Director for Clinical Science at the Lester and Sue Smith Breast Center and Director of Translational Research for the Breast Cancer Research Program. Dr. Lim earned her medical degree from Ewha Womans University School of Medicine in Seoul, South Korea.
Associate Professor
Medical School
1998 – 2004
Residency
2007 – 2010
Fellowship
2011 – 2014